These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 9832459

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
    Duong LT, Lakkakorpi PT, Nakamura I, Machwate M, Nagy RM, Rodan GA.
    J Clin Invest; 1998 Sep 01; 102(5):881-92. PubMed ID: 9727056
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts.
    Woo JT, Kasai S, Stern PH, Nagai K.
    J Bone Miner Res; 2000 Apr 01; 15(4):650-62. PubMed ID: 10780857
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Histomorphometric evidence for echistatin inhibition of bone resorption in mice with secondary hyperparathyroidism.
    Masarachia P, Yamamoto M, Leu CT, Rodan G, Duong L.
    Endocrinology; 1998 Mar 01; 139(3):1401-10. PubMed ID: 9492077
    [Abstract] [Full Text] [Related]

  • 10. Dexamethasone inhibits the formation of multinucleated osteoclasts via down-regulation of beta3 integrin expression.
    Kim YH, Jun JH, Woo KM, Ryoo HM, Kim GS, Baek JH.
    Arch Pharm Res; 2006 Aug 01; 29(8):691-8. PubMed ID: 16964765
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells.
    Wesolowski G, Duong LT, Lakkakorpi PT, Nagy RM, Tezuka K, Tanaka H, Rodan GA, Rodan SB.
    Exp Cell Res; 1995 Aug 01; 219(2):679-86. PubMed ID: 7641819
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor.
    Jones JI, Prevette T, Gockerman A, Clemmons DR.
    Proc Natl Acad Sci U S A; 1996 Mar 19; 93(6):2482-7. PubMed ID: 8637900
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts.
    Nakamura I, Takahashi N, Sasaki T, Jimi E, Kurokawa T, Suda T.
    J Bone Miner Res; 1996 Dec 19; 11(12):1873-9. PubMed ID: 8970888
    [Abstract] [Full Text] [Related]

  • 19. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis.
    Horton MA, Dorey EL, Nesbitt SA, Samanen J, Ali FE, Stadel JM, Nichols A, Greig R, Helfrich MH.
    J Bone Miner Res; 1993 Feb 19; 8(2):239-47. PubMed ID: 7680185
    [Abstract] [Full Text] [Related]

  • 20. Significance of RGD loop and C-terminal domain of echistatin for recognition of alphaIIb beta3 and alpha(v) beta3 integrins and expression of ligand-induced binding site.
    Marcinkiewicz C, Vijay-Kumar S, McLane MA, Niewiarowski S.
    Blood; 1997 Aug 15; 90(4):1565-75. PubMed ID: 9269775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.